| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
|
Ghobadi, Armin
|
|
2019
|
19 |
10 |
p. e588-e593
|
artikel
|
| 2 |
Breast Implant-associated Plasmablastic Lymphoma: A Case Report and Discussion of the Literature
|
Geethakumari, Praveen Ramakrishnan
|
|
2019
|
19 |
10 |
p. e568-e572
|
artikel
|
| 3 |
Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System
|
Jung, Ki Sun
|
|
2019
|
19 |
10 |
p. 656-664
|
artikel
|
| 4 |
Editorial Board
|
|
|
2019
|
19 |
10 |
p. A4-A5
|
artikel
|
| 5 |
Familial Cancer: How to Successfully Recruit Families for Germline Mutations Studies? Multiple Myeloma as an Example
|
Blocka, Joanna
|
|
2019
|
19 |
10 |
p. 635-644.e2
|
artikel
|
| 6 |
Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome
|
Hanbali, Amr
|
|
2019
|
19 |
10 |
p. 670-677
|
artikel
|
| 7 |
Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent Prognosis
|
Kriegsmann, Katharina
|
|
2019
|
19 |
10 |
p. e581-e587
|
artikel
|
| 8 |
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments
|
Visentin, Andrea
|
|
2019
|
19 |
10 |
p. 678-685.e4
|
artikel
|
| 9 |
Refractory α/β-Hepatosplenic T-cell Lymphoma With Secondary CNS Dissemination and Severe Morbidity Related to Intrathecal Chemotherapy: A Case Report and Literature Review
|
Lewis, Katharine L.
|
|
2019
|
19 |
10 |
p. e564-e567
|
artikel
|
| 10 |
Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature
|
Slot, Stefanie
|
|
2019
|
19 |
10 |
p. 624-634
|
artikel
|
| 11 |
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities
|
Ailawadhi, Sikander
|
|
2019
|
19 |
10 |
p. 619-623
|
artikel
|
| 12 |
Table of Contents
|
|
|
2019
|
19 |
10 |
p. A6-A7, A13
|
artikel
|
| 13 |
Temozolomide as a Single Agent Maintenance Therapy in Elderly Patients With Primary CNS Lymphoma
|
Faivre, Geraldine
|
|
2019
|
19 |
10 |
p. 665-669
|
artikel
|
| 14 |
Testicular Myeloid Sarcoma: A Systematic Review of the Literature
|
Sahu, Kamal Kant
|
|
2019
|
19 |
10 |
p. 603-618
|
artikel
|
| 15 |
The Lymphoma-Associated Macrophage to Hodgkin-Reed-Sternberg Cell Ratio Is a Poor Prognostic Factor in Classic Hodgkin Lymphoma Patients
|
Procházka, Vít
|
|
2019
|
19 |
10 |
p. e573-e580
|
artikel
|
| 16 |
Therapeutic Potential of Checkpoint Inhibitors in Refractory Plasmablastic Lymphoma
|
Damlaj, Moussab
|
|
2019
|
19 |
10 |
p. e559-e563
|
artikel
|
| 17 |
Treatment Patterns and Clinical and Economic Outcomes in Patients With Newly Diagnosed Multiple Myeloma Treated With Lenalidomide- and/or Bortezomib-containing Regimens Without Stem Cell Transplant in a Real-world Setting
|
Chari, Ajai
|
|
2019
|
19 |
10 |
p. 645-655
|
artikel
|
| 18 |
Venetoclax in Immunoglobulin Light Chain Amyloidosis: Is This the Beginning or the End?
|
Premkumar, Vikram
|
|
2019
|
19 |
10 |
p. 686-688
|
artikel
|
Tijdschrift beschrijving